Mahindra Gdr Reg-s is related to 2 other symbols. To date we've encountered 6 releases involving Mahindra Gdr Reg-s.
Last Price: 4.65 (+0.70) - 12/11/2008,
4:56am
A "business partner" is defined as a third party company that has co-released at least one press release with Mahindra Gdr Reg-s.
WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it has successfully detected the primary protein biomarker from its prostate cancer diagnostic, using an ELISA based immunoassay.
WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting at BioContact Quebec 2006 in Quebec City, October 4-6.
WINNIPEG, MANITOBA (MARKET WIRE)
WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it is expanding its product pipeline to include new diagnostic research programs for pancreatic and stomach cancer.
WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce the successful completion of the validation study for its prostate cancer diagnostic program.
WINNIPEG, MANITOBA (MARKET WIRE) Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce a collaboration agreement with Fox Chase Cancer Center in Philadelphia, to further the development of the Miraculins' colorectal cancer diagnostic project.
Contacts: Miraculins Inc. Christopher J. Moreau Vice President Business Development (204) 477-7599 (204) 453-1546 (FAX) info@miraculins.com www.miraculins.com
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.